SHLP-5

Longevity / senescence / mitochondrial

Aging biology, resilience, and durable cellular-function support

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Longevity / geroprotector compound
Primary mechanism: Senescence, telomere, mitochondrial, or cellular stress pathway modulation
Primary market use: Longevity / senescence / mitochondrial

Pharmacology

Molecular weight (Da): 2565.93
Oral bioavailability: Route-dependent / verify
Half-life: ~5–60 min parent peptide; analogs may be longer
Route tags: SubQ; Injectable; route-dependent
Evidence level: MCE product listing / research chemical signal
Clinical status: Research chemical/reference listing
Value-for-money score: 8 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

SHLP-5 is a mitochondrial-derived peptide, a biologically active microprotein encoded by the 16s ribosomal RNA (MT-RNR2) gene. SHLP-5 can be used in the research of diabetes, Alzheimer's disease, cardiovascular disease and prostate cancer .

Sources

https://www.medchemexpress.com/shlp-5.html